North America Dietary Supplements Market Analysis By Ingredient (Botanicals, Vitamins, Minerals), By Product (Tablets, Capsules, Gel Caps), By Application, By End-use, And Segment Forecasts, 2014 - 2025

The North America dietary supplements market is expected to reach USD 68.22 billion by 2025, according to a new report by Grand View Research, Inc. Rising consumer awareness regarding proper weight management and improvement of muscular strength is likely to boost the demand of nutrients such as vitamins, minerals, and enzymes in North America, over the years ahead.
Consumers belonging to all age groups are focusing on enhancing their diet intake through utilization of nutritional food ingredients, owing to increasing publicity through media houses and e-commerce portals is expected to promote the scope of nutraceuticals including dietary supplements.
Leading corporates including Microsoft, IBM, ExxonMobil, AT&T, GM, and GSK have increased expenditure for the development of gymnasiums and fitness centers in their commercial offices. As a result, the health & wellness segment is expected to witness a noteworthy increase that is ultimately expected to play a crucial role in promoting the use of dietary supplements over the forecast period.
Further key findings from the report suggest:
‧ In terms of revenue, minerals segment is estimated to be one of the fastest growing segments and is likely to expand at a CAGR of 6.7% over the forecast period, owing to significant usage of mineral-based dietary supplements in the U.S. and Canada
‧ Liquid product segment is expected to provide considerable scope for market growth and is estimated to account for a revenue of USD 10.40 billion by 2025, as a consequence of rising clinical nutrition products demand for prevention of malnutrition
‧ Medicinal supplements application constituted a revenue of USD 6.40 billion in 2016 and is likely to expand at a robust growth rate by 2025, owing to rising health risks pertaining to cardiovascular, obesity, and gastrointestinal disorders
‧ Mexico is projected to witness fastest industry growth during the forecast period, owing to rising usage of ingredients such as botanicals and vitamins among children, infants, and adult age groups
‧ Amway Corporation, Pfizer Inc., NBTY, Inc., and Herbalife International are the key players that collectively accounted for over 15% market share of the global industry in 2016
‧ Companies are focusing on strengthening their presence as key players, by forward integrating their business operations across the value chain and through implementing strategies such as distribution agreements and new product launches. In April 2016, Amway Corporation launched a new sports nutrition product line to cater to the regional demand.

Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
1.4. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. North America Dietary Supplements Market Variables, Trends, & Scope
3.1. Market segmentation
3.2. Penetration and growth prospects mapping
3.3. Value chain analysis
3.4. Technology overview
3.5. Regulatory framework
3.6. Market dynamics
3.6.1. Market driver analysis
3.6.1.1. Rising importance towards fitness
3.6.1.2. Product innovation in sports nutrition
3.6.1.3. Growing medical nutrition market
3.6.2. Market restraint analysis
3.6.2.1. Rising demand for organic foods
3.6.2.2. Improvement in functional foods market
3.7. Industry analysis - Porter's
3.8. PESTEL analysis, 2016
Chapter 4. North America Dietary Supplements: Ingredient Estimates & Trend Analysis
4.1. Ingredient movement analysis & market share, 2016 & 2025
4.2. Botanicals
4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
4.3. Vitamins
4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.3.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
4.4. Minerals
4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.4.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
4.5. Amino Acids
4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.5.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
4.6. Enzymes
4.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.6.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
4.7. Others
4.7.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.7.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
Chapter 5. North America Dietary Supplements: Product Estimates & Trend Analysis
5.1. Product movement analysis & market share, 2016 & 2025
5.2. Tablets
5.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.2.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.3. Capsules
5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.3.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.4. Powder
5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.4.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.5. Liquid
5.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.5.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.6. Soft Gels
5.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.6.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.7. Gel Caps
5.7.1. Market estimates and forecast, 2014 - 2025 (USD Million)
5.7.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
Chapter 6. North America Dietary Supplements: Application Estimates & Trend Analysis
6.1. Application movement analysis & market share, 2016 & 2025
6.2. Additional Supplements
6.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.2.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
6.3. Medicinal Supplement
6.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.3.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
6.4. Sports Nutrition
6.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
Chapter 7. North America Dietary Supplements: End-use Estimates & Trend Analysis
7.1. End-use movement analysis & market share, 2016 & 2025
7.2. Infant
7.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
7.2.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
7.3. Children
7.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
7.3.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
7.4. Adults
7.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
7.4.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
7.5. Pregnant women
7.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
7.5.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
7.6. Old-aged
7.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
7.6.2. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
Chapter 8. North America Dietary Supplements: Regional Estimates & Trend Analysis
8.1. Country movement analysis & market share, 2016 & 2025
8.2. North America
8.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
8.2.2. Market estimates and forecast, by ingredient, 2014 - 2025 (USD Million)
8.2.3. Market estimates and forecast, by product, 2014 - 2025 (USD Million)
8.2.4. Market estimates and forecast, by application, 2014 - 2025 (USD Million)
8.2.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
8.2.6. U.S.
8.2.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
8.2.6.2. Market estimates and forecast, by ingredient, 2014 - 2025 (USD Million)
8.2.6.3. Market estimates and forecast, by product, 2014 - 2025 (USD Million)
8.2.6.4. Market estimates and forecast, by application, 2014 - 2025 (USD Million)
8.2.6.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
8.2.7. Canada
8.2.7.1. Market estimates and forecast, 2014 - 2025 (USD Million)
8.2.7.2. Market estimates and forecast, by ingredient, 2014 - 2025 (USD Million)
8.2.7.3. Market estimates and forecast, by product, 2014 - 2025 (USD Million)
8.2.7.4. Market estimates and forecast, by application, 2014 - 2025 (USD Million)
8.2.7.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
8.2.8. Mexico
8.2.8.1. Market estimates and forecast, 2014 - 2025 (USD Million)
8.2.8.2. Market estimates and forecast, by ingredient, 2014 - 2025 (USD Million)
8.2.8.3. Market estimates and forecast, by product, 2014 - 2025 (USD Million)
8.2.8.4. Market estimates and forecast, by application, 2014 – 2025
8.2.8.5. Market estimates and forecast, by end-use, 2014 – 2025
Chapter 9. Competitive Landscape
9.1. Company market share, 2016
9.2. Vendor landscape
9.3. Competitive environment
9.4. Company market positioning
9.5. Strategic framework
Chapter 10. Company Profiles
10.1. Amway
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Abbott Laboratories
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Arkopharma Laboratoires Pharmaceutiques
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.4. Bayer AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.5. Glanbia
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.6. Pfizer
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. Carlyle Group, NBTY, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.8. GlaxoSmithKline
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.9. Herbalife Limited, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Nature’s Sunshine Products
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.11. Bionova Lifesciences
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.12. Ayanda Group AS
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.13. XanGo LLC
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.14. American Health
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.15. Neutraceutics Corporation
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking